Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-05-18 @ 6:50 AM
Study NCT ID:
NCT00737932
Status:
COMPLETED
Last Update Posted:
2015-03-20
First Post:
2008-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Laquinimod Phase IIa Study in Active Crohn's Disease
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CD-LAQ-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None